Introduction
pGHD
GROWTH HORMONE DEFICIENCY
Edited by: Sandro Loche, Ospedale Pediatrico Microcitemico “A. Cao”, ItalyReviewed by: Martin Oswald Savage, Queen Mary University of London, United Kingdom; Marco Cappa, Bambino Gesù Children’s Hospital (IRCCS), Italy†Present address: Diane M. Turner-Bowker, Endpoint Development and Strategy, Ultragenyx, Novato, CA, United States‡ORCID: Roy Gomez, The standard of care for pediatric growth hormone deficiency (pGHD) is once-daily recombinant human growth hormone (rhGH). Somatrogon, a long-acting rhGH, requires less frequent, once-weekly, dosing. We describe physicians’ preference for, experiences, and satisfaction with once-weekly somatrogon vs once-daily rhGH.